EUVIMEDEUVIMED entdecken
Open Access

Unique Pathology in the Locus Coeruleus of Individuals with Down Syndrome

Hannah Saternos, Eric D Hamlett, Samuel Guzman, Elizabeth Head, Ann-Charlotte Granholm, Aurélie Ledreux

Journal of Alzheimer’s Disease · 2024

DOI: 10.3233/jad-240043 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, 2024. Verfasst von Hannah Saternos und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. Hauptthemen laut MEDLINE: Down Syndrome, Locus Coeruleus, tau Proteins, Alzheimer Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 156 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Down syndrome (DS) is one of the most commonly occurring chromosomal conditions. Most individuals with DS develop Alzheimer’s disease (AD) by 50 years of age. Recent evidence suggests that AD pathology in the locus coeruleus (LC) is an early event in sporadic AD. It is likely that the widespread axonal network of LC neurons contributes to the spread of tau pathology in the AD brain, although this has not been investigated in DS-AD.

Objective

The main purpose of this study was to profile AD pathology and neuroinflammation in the LC, comparing AD and DS-AD in postmortem human tissues.

Methods

We utilized immunofluorescence and semi-quantitative analyses of pTau (4 different forms), amyloid-β (Aβ), glial, and neuronal markers in the LC across 36 cases (control, DS-AD, and AD) to compare the different pathological profiles.

Results

Oligomeric tau was highly elevated in DS-AD cases compared to LOAD or EOAD cases. The distribution of staining for pT231 was elevated in DS-AD and EOAD compared to the LOAD group. The DS-AD group exhibited increased Aβ immunostaining compared to AD cases. The number of tau-bearing neurons was also significantly different between the EOAD and DS-AD cases compared to the LOAD cases.

Conclusions

While inflammation, pTau, and Aβ are all involved in AD pathology, their contribution to disease progression may differ depending on the diagnosis. Our results suggest that DS-AD and EOAD may be more similar in pathology than LOAD. Our study highlights unique avenues to further our understanding of the mechanisms governing AD neuropathology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Down SyndromeLocus Coeruleustau ProteinsAlzheimer DiseaseAmyloid beta-PeptidesHumansMaleFemaleMiddle AgedAgedNeuronsAged, 80 and overAdult

Stichwörter der Autor:innen

Alzheimer’s diseaseDown syndromeamyloid-betaastrocytelocus coeruleusmicrogliatau

Substanzen

tau ProteinsAmyloid beta-Peptides

Autor:innen und Institutionen

  • Department of Neurosurgery, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC, USA.
  • Department of Pathology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Department of Pathology and Laboratory Medicine, University of California at Irvine, Irvine, CA, USA.

Förderung

  • NIA NIH HHS

Zitieren

APA

Saternos, H., Hamlett, E. D., Guzman, S., Head, E., Granholm, A. C., & Ledreux, A. (2024). Unique Pathology in the Locus Coeruleus of Individuals with Down Syndrome. Journal of Alzheimer’s Disease. https://doi.org/10.3233/jad-240043

Vancouver

Saternos H, Hamlett ED, Guzman S, Head E, Granholm AC, Ledreux A. Unique Pathology in the Locus Coeruleus of Individuals with Down Syndrome. Journal of Alzheimer’s Disease. 2024. doi:10.3233/jad-240043

BibTeX
@article{Saternos2024,
  author = {Saternos, Hannah and Hamlett, Eric D and Guzman, Samuel and Head, Elizabeth and Granholm, Ann-Charlotte and Ledreux, Aurélie},
  title = {Unique Pathology in the Locus Coeruleus of Individuals with Down Syndrome},
  journal = {Journal of Alzheimer’s Disease},
  year = {2024},
  doi = {10.3233/jad-240043}
}
Kostenlos starten →